Schoenwald, RD; Gadiraju, RR; Barfknecht, CF. Serotonin antagonists for use as antiglaucoma agents and their ocular penetration. Eur. J. Pharm. Biopharm., 1 Jun 1997, 43 (3), 273–281. 688 kB. https://doi.org/10.1016/S0939-6411(97)00055-6 #3
Helm, K. Synthese und funktionelle In-vitro-Pharmakologie neuer Liganden des 5-HT2A-Rezeptors aus der Klasse. Ph. D. Thesis, Universität Regensburg, Dresden, 1 Jan 2014. 3.2 MB. #70 LC,MS,NMR,IR
Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry. Talanta, 15 Feb 2009, 77 (4), 1245–1272. 1.2 MB. https://doi.org/10.1016/j.talanta.2008.07.062 #PP GC,LC,MS,UV
Glennon, RA; Slusher, RM; Lyon, RA; Titeler, M; McKenney, JD. 5-HT1 and 5-HT2: Binding characteristics of some quipazine analogs. J. Med. Chem., 1 Nov 1986, 29 (11), 2375–2380. 819 kB. https://doi.org/10.1021/jm00161a038 #11 other
Martins, D; Garrido, EMPJ; Borges, F; Garrido, JMPJ. Voltammetric profiling of new psychoactive substances: Piperazine derivatives. J. Electroanal. Chem., 1 Feb 2021, 883 (115054). 1.2 MB. https://doi.org/10.1016/j.jelechem.2021.115054 #PhPIP other